Molecular Aspects of Defibrination in a Case of Amniotic Fluid Embolism

H Graeff; R Hafter; R von Hugo

doi:10.1055/s-0038-1651890

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1977; 38(03): 0724-0727
DOI: 10.1055/s-0038-1651890

Letters to the Editor

Schattauer GmbH

Molecular Aspects of Defibrination in a Case of Amniotic Fluid Embolism

H Graeff

¹I. Frauenklinik der Universität München, Maistraße 11, 8000 München 2, Germany

,

R Hafter

¹I. Frauenklinik der Universität München, Maistraße 11, 8000 München 2, Germany

,

R von Hugo

¹I. Frauenklinik der Universität München, Maistraße 11, 8000 München 2, Germany

References
1 Benabid Y, Concord E, Suscillon M. 1977; Soluble fibrin complexes: Separation as a function of pH and characterization. Thrombosis and Haemostasis 37: 144.
2 Gaffney P. J. 1975; Distinction between fibrinogen and fibrin degradation products in plasma. Clinica Chimica Acta 65: 109.
3 Graeff H, von Hugo R, Hafter R. 1976. Derivate des Fibrins in der Perinatalperiode. In: Schroer H, Hauck H, Zimmermann E. (eds.) Struktur und Funktion des Fibrinogens. F. K. Schattauer Verlag; Stuttgart–New York: 81.
4 Graeff H, von Hugo R, Hafter R. 1977. Evaluation of hypercoagulability and intravascular coagulation by estimation and characterization of soluble fibrin monomer complexes (SFMC). In: Davidson J. F, Samama M. M, Desnoyers P. C. (eds.) Progress in Chemical Fibrinolysis and Thrombolysis. Vol. 3 Raven Press; New York: in press.
5 Hafter R, Graeff H. 1976. Estimation of soluble fibrin monomer complexes by agarose gel filtration. In: Davidson J. F, Samama M. M, Desnoyers P. C. (eds.) Progress in Chemical Fibrinolysis and Thrombolysis. Vol. 2 Raven Press; New York: 137.
6 Hafter R, Müller-Berghaus G, von Hugo R, Graeff H. 1977; Estimation and characterization of soluble fibrin monomer complexes during endotoxin-induced intravascular coagulation. Thrombosis Research 10: 111.
7 von Hugo R, Graeff H. 1973; Fibrin-i degradation products with a molecular weight higher than that of fibrinogen. Identification and characterization of in vitro products from human plasma. Thrombosis et Diathesis Haemorrhagica 29: 122.
8 Lane D. A, Scully M. F, Kakkar V. V. 1976; A method for characterising serum fibrinogen and fibrin degradation products. Thrombosis Research 9: 191.
9 Ly B, Kierulf P, Jacobsen E. 1974; Stabilisation of soluble fibrin/fibrinogen complexes by fibrin stabilizing factor (FSF). Thrombosis Research 4: 509.
10 Marder V J, Budzynskl A. Z. 1974; Degradation products of fibrinogen and crosslinked fibrin—projected clinical applications. Thrombosis et Diathesis Haemorrhagica 32: 49.